Sana Biotechnology presents updated corporate deck at Goldman Sachs conference

Sana Biotechnology, Inc.

Company discussed updated corporate presentation at Goldman Sachs 43rd Annual Global Healthcare Conference on June 14, 2022.
No specific financial or pipeline data disclosed in the filing; presentation content not fully reproduced.
Filing is a routine Reg FD disclosure; no material changes to previously announced information evident.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.